Showing results (81-90 of 199) with videos related to
Sort By:
Pageof 20
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.Neurosurgery|October 7, 2020
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive GlioblastomaDavid M Peereboom, Xiaobu Ye, Tom Mikkelsen, et al.Neuro-Oncology|February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.Journal of Neuro-Oncology|March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant gliomaSurasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.Journal of Neuro-Oncology|November 28, 2023
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, et al.Journal of Neuro-Oncology|January 7, 2014
Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sectionsSteven N Kalkanis, Rachel E Kast, Mark L Rosenblum, et al.Neuro-Oncology Advances|July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastomaSamuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.Cancer Research|October 5, 2006
High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalancesYuri Kotliarov, Mary Ellen Steed, Neil Christopher, et al.Nanomedicine (London, England)|August 16, 2012
A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of gliomaMeser M Ali, Mohammed Pi Bhuiyan, Branislava Janic, et al.Cancer Biology & Therapy|February 1, 2007
Proteomic comparison of oligodendrogliomas with and without 1pLOHHiroaki Okamoto, Jie Li, Sven Gläsker, et al.Pageof 20